>Brookings Oregon News, Sports, & Weather | The Curry Coastal Pilot

News Classifieds Web
web powered by Web Search Powered by Google

News arrow News arrow Business arrow MOTEL UNDER NEW OWNERSHIP

MOTEL UNDER NEW OWNERSHIP Print E-mail
October 05, 2007 11:00 pm

By Ellen Babin

Pilot staff writer

After working since he was 15 in the hotel/motel business, Ken Bryan is trying something new – owning one.

After little more than a week owning Wild Rivers Motorlodge in Brookings, Ken, his wife Connie and one of their three sons, Eric, are divvying up the chores and learning the ins and outs of being in charge of everything little – and big.

After starting his career as a youth by smashing cardboard boxes in exchange for meals, Ken has 30 years experience in the hotel industry. His met his wife in a hotel in Klamath Falls.

He has worked in Colorado, Washington, Oregon, California, Montana and Idaho; the last of his jobs was the manager of a hotel in Pocatello, Idaho.

Missing the Oregon Coast and wanting to do something he hadn't done yet in the industry, Ken started looking for a motel that could sustain itself.

With help from hotel brokers and some luck, the family found the Wild Rivers Motorlodge, which proved to have a little more year round business, Ken said.

In addition, he said, the motel is the size he could operate with help from his wife and son, who wants to eventually run the business.

Connie, Eric and Ken

"literally do everything," pertaining to the business, Ken said.

His wife does the housekeeping, Eric is in charge of "engineering," including keeping up the grounds, and Ken is in charge of the front

desk and he helps with

the laundry.

Connie, Ken says, is his "right hand person, It is very much a partnership."

Wild Rivers Motorlodge has 30 rooms, some of the nicest rooms along the coast Ken said.

He has lots of plans pending for his new business, including more renovation and adding additional rooms.

For now, Ken is going to repaint red, white,and blue the three canoes that are the motel's focal point.

"My patriotic view is evident in all I do," Ken said.

He believes in being active in the community in which he lives. "After things run smoothly, I'd like to get involved in local politics," he said.

 

Business News by Yahoo Finance

  • Economy seen regaining muscle in second quarter
    U.S. economic growth likely regained steam in the second quarter as activity picked up broadly, which would bolster expectations for a stronger performance in the last six months of the year. Gross domestic product likely grew at a 3.0 percent annual rate after shrinking at a 2.9 percent pace in the first quarter, according to a Reuters survey of economists. "I don't think the contraction we saw in the first quarter is reflective of what's truly going on in the economy," said Gus Faucher, senior economist at PNC Financial Services Group in Pittsburgh. Earlier in the second quarter, growth estimates were as high as 4 percent, but they were cut as trade, consumer spending and business investment rebounded from the winter slump by less than expected.
  • Asian shares hit six and a half year high, dollar steady before Fed
    Asian shares touched a six-and-half-year peak on Wednesday and the dollar was steady, with investors waiting for second quarter U.S. growth data as well as a U.S. Federal Reserve meeting that some believe might yield a more hawkish policy outlook. The Fed will not be updating its economic forecasts and Chair Janet Yellen will not hold a news conference following the two-day policy meeting, leaving investors' focus squarely on a statement scheduled to be released at 2 p.m. (18:00 GMT).
  • AstraZeneca buys Almirall lung drugs for up to $2.1 billion
    AstraZeneca (AZN.L) took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's (ALM.MC) lung drugs. The British drugmaker, which resisted a $118 billion takeover attempt by Pfizer (PFE.N) in May, said it would pay an initial $875 million and up to $1.22 billion more if the drugs meet development and sales targets. The tie-up boosts a key therapeutic area for AstraZeneca, whose Chief Executive Pascal Soriot is determined to show his company has a strong independent future. Soriot also struck a clinical trial collaboration with Japan's Kyowa Hakko Kirin (4151.T) for a study that will evaluate a combination of the two companies' drugs in cancer - another important field for AstraZeneca.

Follow Curry Coastal Pilot headlines on Follow Curry Coastal Pilot headlines on Twitter

© Copyright 2001 - 2014 Western Communications, Inc. All rights reserved. By Using this site you agree to our Terms of Use